29 May 2024

Assura plc

Notice of Dividend

Assura plc ("Assura" or "the Company"), the specialist healthcare property investor and developer, today announces that the next quarterly interim dividend of 0.84 pence per share will be paid on 10 July 2024 to shareholders on the register on 7 June 2024 (the "Record Date"). The Ex-dividend Date will be 6 June 2024.

This interim dividend will be wholly Property Income Distribution ("PID"). Forms to register for gross PIDs are available on the Company's website and must be returned to the Company registrars, Link Group at Central Square, 29 Wellington Street, Leeds, LS1 4DL to arrive by 4.30pm on 28 June 2024. Please refer to Company's website HERE for more information.

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 13 June 2024.

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 28 June 2024 either to return their completed mandate form to the Company registrars, Link Group at Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

- Ends -

For more information, please contact:

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.